Novel ALK mutation with durable response to brigatinib—a case report

por Latif, Hira, Liu, Stephen V.
Publicado 2020

Chemo-immunotherapy as first-line treatment for small-cell lung cancer

por Farid, Saira, Liu, Stephen V.
Publicado 2020

NSCLC With Synchronous EGFR Mutations in Li Fraumeni Syndrome: A Case Report

por Marks, Jennifer A., Liu, Stephen V.
Publicado 2023

Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential

por Armstrong, Samantha A., Liu, Stephen V.
Publicado 2019

Tracking the tail

por Friedlaender, Alex, Liu, Stephen V, Addeo, Alfredo
Publicado 2020

Drugs in development for small cell lung cancer

por Serzan, Michael T., Farid, Saira, Liu, Stephen V.
Publicado 2020

Breast metastasis from nasopharyngeal carcinoma: A case report and review of the literature

por LEACH, BEN I., SUN, BONNIE, PETROVIC, LYDIA, LIU, STEPHEN V.
Publicado 2013

Oral Chemotherapy for Treatment of Lung Cancer

por Jonna, Sushma, Reuss, Joshua E., Kim, Chul, Liu, Stephen V.
Publicado 2020

Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung Cancer

por Riano, Ivy, Patel, Shruti R., Liu, Stephen V., Duma, Narjust
Publicado 2021

EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists

por Liu, Stephen V., Elkins, Ivy B., Feldman, Jill, Goldberg, Sarah B.
Publicado 2023

EML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report

por von Buttlar, Xinyu, Reuss, Joshua E., Liu, Stephen V., Kim, Chul
Publicado 2021

Epigenetic Therapy in Lung Cancer

por Liu, Stephen V., Fabbri, Muller, Gitlitz, Barbara J., Laird-Offringa, Ite A.
Publicado 2013

First-Line Pembrolizumab Plus Chemotherapy for Advanced Squamous NSCLC: Real-World Outcomes at U.S. Oncology Practices

por Liu, Stephen V., Rai, Pragya, Wang, Dong, Hu, Xiaohan, Schwarzenberger, Paul Otto
Publicado 2022

Use of on-therapy ctDNA monitoring in a patient with KIF5B-RET fusion positive advanced non-small cell lung cancer: a case report

por Yeung, Vincent, Kim, Chul, Kiedrowski, Lesli A., Liu, Stephen V., Reuss, Joshua E.
Publicado 2022

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

por Liu, Stephen V., Hu, Xiaohan, Li, Yeran, Zhao, Bin, Burke, Thomas, Velcheti, Vamsidhar
Publicado 2022

A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer

por Subramaniam, Deepa S., Liu, Stephen V., Crawford, Jeanette, Kramer, Jenna, Thompson, Jillian, Wang, Hongkun, Giaccone, Giuseppe
Publicado 2018

Phase I study of the (177)Lu-DOTA(0)-Tyr(3)-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung

por Kim, Chul, Liu, Stephen V, Subramaniam, Deepa S, Torres, Tisdrey, Loda, Massimo, Esposito, Giuseppe, Giaccone, Giuseppe
Publicado 2020

Drugging KRAS: current perspectives and state-of-art review

por Parikh, Kaushal, Banna, Giuseppe, Liu, Stephen V., Friedlaender, Alex, Desai, Aakash, Subbiah, Vivek, Addeo, Alfredo
Publicado 2022

The Applicability of the Results in the Asian Population of ORIENT-11 to a Western Population According to the ICH-E5 Framework

por Liu, Stephen V., Nagasaka, Misako, Stefaniak, Victoria, Gruver, Kristi, Lin, Yong, Ferry, David, Socinski, Mark A., Zhang, Li
Publicado 2022

Response to Entrectinib in Differentiated Thyroid Cancer With a ROS1 Fusion

por Liu, Stephen V., Macke, Laura A., Colton, Bradley S., Imran, Sikandar S., Christiansen, Jason, Chow-Maneval, Edna, Hornby, Zachary, Multani, Pratik S.
Publicado 2017